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Abstract Studies on colorectal carcinogenesis have suggested a
critical role of the adenomatous polyposis coli (APC) gene in
the development of colorectal cancer. Gut-enriched Kru«ppel-like
factor (GKLF) is a zinc-¢nger transcription protein with high
expression in the colonic epithelium. Our previous studies have
shown that GKLF transcript was signi¢cantly decreased in co-
lon cancer tissue and suggested that it might play a role in the
tumorigenesis of the colon. The signaling pathway of GKLF-
regulated cell growth is currently unknown. We sought to de-
termine if the functions of GKLF are mediated through the
APC/L-catenin pathway. In a colon cancer cell line (HT29-
APC), containing a zinc-inducible APC gene, GKLF mRNA
levels were signi¢cantly increased when wild-type APC protein
was induced. No e¡ect on GKLF mRNA concentration was
observed in a control cell line (HT29-L-gal), containing an anal-
ogous inducible lacZ gene. GKLF promoter activity was induced
by co-transfection with wild-type APC DNA, suggesting that
APC might be involved in transcriptional activation of the
GKLF gene. In HT-29 cells, overexpression of GKLF resulted
in decreases in L-catenin protein and mRNA levels and down-
regulation of GKLF expression led to increase in L-catenin con-
centration. Overexpression of GKLF in HT-29 cells inhibited
DNA synthesis and this e¡ect was attenuated by co-transfection
with wild-type L-catenin, suggesting an essential role of L-cat-
enin in GKLF signaling. Furthermore, co-transfection of GKLF
in colon cancer SW 480 cells abrogated the transcriptional ac-
tivity of a L-catenin-T-cell factor (Tcf) reporter construct in a
dose-dependent manner. These ¢ndings indicate that the growth-
suppressive e¡ect of GKLF may be mediated through the APC/
L-catenin pathway. We speculate that when APC is mutated,
GKLF gene expression is down-regulated, resulting in increases
in L-catenin level and transactivation of growth-promoted genes.
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1. Introduction
Colorectal cancer is one of the most common and poten-
tially fatal diseases encountered in Western countries. Molec-
ular analysis of colon cancer patients has shown that muta-
tions of the adenomatous polyposis coli (APC) gene are
present in the majority of sporadic human colorectal carcino-
mas [1]. The current concept of colonic carcinogenesis begins
with inactivation or loss of the APC gene, followed by sequen-
tial loss of other tumor suppressor genes or activation of
cellular oncogenes. A mutated APC gene produces a trun-
cated protein that lacks the ability to induce degradation of
L-catenin. Free L-catenin then translocates to the cell nucleus,
interacts with T-cell factor 4 (Tcf-4) transcription factor which
then leads to transcriptional activation of several growth-pro-
moting genes including c-Myc and cyclin D1 [2^4].
Recently, a zinc-¢nger transcription factor GKLF (gut-en-
riched Kru«ppel-like factor), also known as Kru«ppel-like factor
4 (KLF4), was found to be expressed extensively in the colon.
Previous studies have shown that GKLF mRNA expression
was enhanced in growth-arrested cells and its level decreased
prior to the initiation of DNA synthesis suggesting that
GKLF might mediate growth arrest [5]. Recently, our labo-
ratory has found that GKLF mRNA levels were signi¢cantly
reduced in human adenomatous polyps and colon cancer tis-
sue, and that overexpression of GKLF in colon cancer cells
signi¢cantly inhibited cyclin D1 activity [6,7]. These results
suggest that down-regulation of GKLF expression might pro-
mote cyclin D1 promoter activity and result in abnormal cell
growth in the colon [7]. As stated above, cyclin D1 appeared
to be one of the downstream targets of the APC/L-catenin
pathway. These data suggest that GKLF and APC may share
similar biological properties. In a murine colon carcinogenesis
model, GKLF mRNA levels were signi¢cantly decreased in
multiple intestinal neoplasia (Min) mice possessing mutated
APC (APC3/3) protein when compared to wild-type
(APC+/+) mice [8]. These results also indicate that the expres-
sion of GKLF may be regulated by APC. We therefore hy-
pothesized that the growth-inhibitory e¡ect of GKLF might
be mediated through the APC/L-catenin pathway and current
studies were undertaken to explore these possibilities.
2. Materials and methods
2.1. Cell culture and creation of stable cell lines
A human colon adenocarcinoma cell line (HT29-APC), containing
a zinc-inducible APC gene and a control cell line (HT29-L-gal), con-
taining an analogous inducible lacZ gene, were kindly provided by
Dr. Vogelstein (Johns Hopkins University, Baltimore, MD, USA).
When HT29-APC cells were cultured in the presence of 100 WM
zinc up to 9 h, the wild-type APC protein was induced [9]. Two
additional human colon adenocarcinoma cell lines, HT-29 and SW
48 (APC+/+), were obtained from the American Type Culture Col-
lection (ATCC, Rockville, MD, USA) and SW 480 (APC3/3) was
also kindly provided by Dr. Vogelstein. All cells were cultured at 37‡C
in a 95% air plus 5% CO2 atmosphere in McCoy’s 5A medium (Life
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Technologies, Inc., Gaithersburg, MD, USA) supplemented with 10%
fetal bovine serum, 100 Wg/ml streptomycin and 100 U/ml penicillin.
Previous studies from this laboratory have shown that Arg390 of
human GKLF confers its nucleus localization signal and that muta-
tion of Arg390 to Ser (RR/RS) completely abolishes the growth-inhib-
itory e¡ect of GKLF [10]. To explore the signaling pathways of
GKLF-mediated cell growth, HT-29 cells were stably transfected
with GKLF or RR/RS mutant DNA using the Lipofectamine method
according to the manufacturer’s protocol (Gibco, Gaithersburg, MD,
USA). To generate stable cell lines, transfected cells were cultured in
the presence of G418 (Gibco) to select neomycin-resistant clones.
After 2^3 weeks, 20 single independent clones were randomly isolated
from each transfection and examined for the expression of the trans-
fected gene by Northern or Western blot analysis.
2.2. Northern blot hybridization analysis
Total RNA from cells was extracted using the acid/phenol method
of Chomczynski and Sacchi [11]. The RNA was then electrophoresed
on a 1.5% agarose/6% formaldehyde gel and Northern blot hybridi-
zation analysis was done using stringent conditions as described pre-
viously [12]. Hybridization was performed using human GKLF,
L-catenin (cDNAs kindly provided by Dr. Vogelstein), or glyceralde-
hyde-3-phosphate dehydrogenase (G3PDH) DNA fragment radiola-
beled with [32P]dCTP using Klenow DNA polymerase I. The blots
were washed under stringent conditions and autoradiograms were
developed after exposure to X-ray ¢lm at 370‡C, using a Cronex
intensifying screen (DuPont, Wilmington, DE, USA).
2.3. Western blot analysis
To obtain whole-cell extracts, cells were washed twice with ice-cold
phosphate-bu¡ered saline (PBS), scraped, and pelleted by centrifuga-
tion (200Ug). Cell pellets were then lysed in a standard RIPA bu¡er
(50 mM Tris^HCl, pH 7.5, 150 mM NaCl, 1.0% NP-40, 0.5% sodium
deoxycholate, and 0.1% SDS) containing protease inhibitors. Protein
concentration of each extract was determined by Bio-Rad Laborato-
ries (Hercules, CA, USA) assays and cell extract was separated on the
SDS^polyacrylamide gel according to the method described by
Laemmli [13]. Protein samples were dissolved in loading bu¡er (60
mM Tris^HCl, pH 6.8, 2% SDS, 100 mM dithiothreitol, and 0.01%
bromophenol blue), heated to 100‡C for 3 min, and loaded onto the
gel in the electrophoresis bu¡er containing 25 mM Tris^HCl, pH 8.3,
250 mM glycine, and 0.1% SDS. At the completion of electrophoresis,
proteins were transferred to a nitrocellulose membrane (Hybond ECL,
Amersham Life Science, Piscataway, NJ, USA). The membrane was
incubated overnight in the blocking bu¡er (10 mM Tris, pH 7.5, 100
mM NaCl, 0.1% Tween 20) containing 5% non-fat powdered milk.
The membrane was immunoblotted with L-catenin, or actin antiserum
(BD Transduction Laboratory, San Diego, CA, USA). To facilitate
transfer of high molecular weight APC protein, electrophoresis was
performed in a 3% low melting agarose gel, as described [9]. A mono-
clonal antibody to APC (Ab-1), reacting with full-length and trun-
cated APC proteins, was used to detect APC proteins (Oncogene
Science, Boston, MA, USA). Following incubation with the secondary
antibody, the membrane was visualized with enhanced chemilumines-
cence (Amersham Life Science).
2.4. DNA content analysis using bromodeoxyuridine (BrdU) labeling
To evaluate the e¡ects of L-catenin on cell growth, the extent of
DNA synthesis was examined in HT-29 cells stably expressing
pcDNA3 or GKLF. Cells were transfected with L-catenin (cDNA
was kindly provided by Dr. Vogelstein) or control pcDNA3 plasmid
using the Lipofectamine PLUS method according to the manufactur-
er’s instruction (Gibco-BRL). Cells were grown in the medium with-
out serum for 48 h and then cultured in the normal medium contain-
ing BrdU to a ¢nal concentration of 10 WM for 30 min. Cells were
washed twice with cold PBS and ¢xed in 70% ethanol on ice for 30
min. Cells were then pelleted and 1 ml of 2 N HCl/Triton X-100 was
added to denature DNA. The acid was neutralized with 0.1 M
Na2B4O7W10 H2O, pH 8.5 and cells were resuspended in 0.5% Tween
20/1% PBS, followed by incubation with anti-BrdU FITC (Becton
Dickinson, San Jose, CA, USA) at room temperature for 30 min.
After washing once in Tween 20/PBS, cells were resuspended in PBS
containing 5 Wg/ml of propidium iodide and analyzed on a £uores-
cence-activated £ow cytometer (FACScan, Becton Dickinson).
2.5. Luciferase and L-galactosidase measurements
To examine transcriptional regulation of GKLF promoter by the
APC gene, the mouse GKLF gene was isolated by screening a liver
genomic V DASH library (Stratagene, La Jolla, CA, USA) using
plaque hybridization. Two positive clones containing GKLF gene
were identi¢ed and subjected to restriction endonuclease digestion
and sequencing ([14], GenBank accession number: AY071827). The
full-length GKLF promoter construct, containing 2200 bp upstream
from the transcriptional initiation site, was ligated to the pGL3-Luc
plasmid (pGKLF-2200). Various truncated promoter constructs were
created by restriction endonuclease digestion or by polymerase chain
reaction using appropriate primers. All constructs were sequenced and
ligated to the pGL3-Luc plasmid containing a ¢re£y luciferase report-
er gene. To examine the e¡ect of APC on GKLF promoter activity,
SW 480 cells were transiently transfected with pCMV gal and pGKLF
DNAs in the presence of APC or control pcDNA3 plasmid using the
Lipofectamine method. Full-length and truncated APC cDNAs (APC
331, APC 1309, APC 1941, and APC 2644) were kindly provided by
Dr. Bert Vogelstein. The APC 331, 1309, 1941, and 2644 proteins
were truncated at codons 331, 1309, 1941 and 2644, respectively [2].
To investigate whether GKLF transactivated L-catenin^Tcf com-
plex, we examined the ability of GKLF to inhibit L-catenin^Tcf-regu-
lated transcription (CRT) in APC3/3 SW 480 cells. Cells were co-
transfected with pCMV-Lgal (0.5 Wg), a reporter construct (0.5 Wg of
pTOPFLASH or pFOPFLASH), and the indicated amount of GKLF
or APC expression vectors using the Lipofectamine method. The
pTOPFLASH reporter contained an optimized Tcf-binding site 5P
of a luciferase reporter gene, whereas the pFOPFLASH plasmid com-
posed of a mutated site that did not bind Tcf [14]. The GKLF (1580)
construct is truncated at codon 1580 of the GKLF cDNA sequence
where all three zinc-¢nger-binding regions are deleted. This construct
was previously shown to be non-functional and was used for negative
control in this study [7].
For luciferase assays, cells were washed twice with PBS 48 h after
transfection and then lysed in 500 Wl of lysis bu¡er following the
manufacturer’s instructions (Analytical Luminescence, San Diego,
CA, USA). To assay luciferase activity, 100 Wl of the cell lysate was
mixed with 100 Wl of luciferase substrate solution A (Analytical Lu-
minescence). Using a luminometer with automatic injection, 100 Wl of
substrate solution B (Analytical Luminescence) was then added, and
luciferase activity was measured as the light emission over a 30 s
period.
L-Galactosidase activity in 40 Wl of the cell lysate was determined
after 5^30 min incubation at 37‡C with 2 mM chlorophenol red
L-galactopyranoside (Boehringer-Mannheim, Indianapolis, IN, USA)
in 2 nM MgCl2, 0.1 mM MnCl2, and 45 mM 2-mercaptoethanol, and
100 mM NaHPO4, pH 8.0. The reactions were stopped by adding 500
Wl of 0.5 M EDTA, pH 8.0, and the absorbance at 570 nm was
measured using a spectrophotometer. With each experiment, luciferase
activity was determined in duplicate and normalized to L-galactosi-
dase activity for each dish.
2.6. Statistics
Results were expressed as meanUS.E.M. Statistical analysis was
performed using analysis of variance and Student’s t-test. A P-value
less than 0.05 was considered to be statistically signi¢cant.
3. Results
3.1. APC regulates GKLF gene expression
The e¡ects of APC on GKLF gene expression were exam-
ined in HT29-APC and HT29-L-gal cells at 3, 6, and 9 h after
ZnCl2 induction. As illustrated in Fig. 1, full-length wild-type
APC protein (FL.APC) ¢rst appeared at 3 h and remained
detectable at 9 h after ZnCl2 induction in HT29-APC cells
(A). In contrast, only mutant APC protein (MT.APC) was
detected in control HT29-L-gal cells (B). These results were
consistent with those reported by Morin et al. [9]. In HT29-
APC cells, the induction of wild-type APC protein is associ-
ated with the increases of GKLF mRNA concentration (C),
whereas no signi¢cant change in GKLF mRNA levels was
observed in HT29-L-gal cells (D). The expression of
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G3PDH mRNA transcript was identical in both HT29-APC
and HT29-L-gal cells (E, F), indicating the speci¢city of APC-
induced GKLF mRNA expression.
3.2. APC transactivates GKLF promoter
To further examine the role of APC in GKLF gene expres-
sion, GKLF promoter constructs were co-transfected with
APC or control pcDNA3 DNA into SW 480 cells. The
pGKLF-2200, pGKLF-515, and pGKLF-250 constructs con-
tained GKLF promoter sequence 32200, 3515, and 3250 bp,
respectively, upstream of the transcriptional initiation site. As
demonstrated in Fig. 2, co-transfection with APC DNA sig-
ni¢cantly increased GKLF promoter activities in the pGKLF-
2200 but not in the pGKLF-515 or pGKLF-250 construct.
These data suggested that APC enhanced GKLF transcrip-
tional activity and that the region between 32200 and 3515
of GKLF promoter is important for APC interaction.
The e¡ect of APC on GKLF promoter activity was eval-
uated by co-transfection with wild-type or truncated APC
DNA [2]. As illustrated in Fig. 3, the stimulatory e¡ect of
APC on GKLF promoter was observed in wild-type (WT)
APC and in truncated APC 1309, APC 1941, or APC 2644
but not in APC 331 constructs, suggesting that the region
between codons 331 and 1309 on the APC DNA was impor-
tant for its function on the GKLF promoter.
3.3. GKLF down-regulated L-catenin expression
The levels of L-catenin protein and mRNA transcript were
examined in wild-type HT-29 and HT-29 cells overexpressing
GKLF or RR/RS GKLF mutant. Previous studies from this
laboratory have shown that a nucleus localization-de¢cient
GKLF mutant (RR/RS) functions as a dominant-negative
inhibitor of the GKLF function [10]. As illustrated in Fig. 4,
L-catenin protein and mRNA levels were signi¢cantly de-
creased in GKLF-expressed HT-29 cells (GKLF). Conversely,
L-catenin protein and mRNA concentrations were signi¢-
cantly induced in cells expressing dominant-negative GKLF
mutant DNA (RR/RS). The concentrations of actin protein
and G3PDH mRNA were identical in these cells indicating
that GKLF may speci¢cally down-regulate L-catenin gene ex-
pression.
3.4. L-Catenin attenuates GKLF-mediated growth inhibition
To further explore the role of L-catenin in GKLF-mediated
growth arrest, DNA synthesis was examined in HT29-
pcDNA3 and HT29-GKLF cells transfected with L-catenin
or control pcDNA3 DNA. Flow cytometric analysis of trans-
fected cells was illustrated on Fig. 5A. As shown in Fig. 5B,
Fig. 2. Induction of GKLF promoter activity by APC. SW 480 cells
were co-transfected with GKLF promoter construct (0.5 Wg) and 0.5
Wg wild-type APC (APC+) or pcDNA3 (APC3 ; as a control). Lu-
ciferase activity was determined 48 h later. pCMV-Lgal (0.1 Wg) was
also co-transfected with each construct to correct for di¡erences in
transfection e⁄ciency. Data are expressed as meansUS.E.M. of four
separate experiments. *P6 0.05, compared to pcDNA3-transfected
cells in each individual construct.
Fig. 3. E¡ects of wild-type APC (WT) or truncated APC 331, 1309,
1941, or 2644 DNA on pGKLF-2200 promoter activity in SW 480
cells. The pGKLF-2200 reporter plasmid (0.5 Wg) was co-transfected
with pCMV-Lgal (0.1 Wg), and 0.5 Wg APC (wild-type or truncated)
cDNA or pcDNA3 (as control). Luciferase activity was determined
48 h later. Data represent the meanUS.E.M. of ¢ve separate experi-
ments.
Fig. 1. Detection of APC protein (A, B), GKLF (C, D), or G3PDH
(E, F) mRNA by Western or Northern blot analysis in HT29-APC
and HT29-Gal cells incubated with 100 WM ZnCl2 for 0, 3, 6, and
9 h. Total protein lysates (80 Wg) were assayed by Western blot
with monoclonal anti-APC antibody, and 20 Wg of total RNA ex-
tracted from cells was subjected to Northern blot analysis using hu-
man GKLF or G3PDH cDNA probe as described in Section 2.
FL.APC: full-length APC protein; MT.APC: mutant truncated
APC protein.
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compared with control cells (HT29-pcDNA3), overexpression
of GKLF (HT29-GKLF) resulted in a signi¢cant decrease in
cells in S-phase, consistent with the growth-inhibitory prop-
erty of GKLF. The decrease in DNA synthesis in HT29-
GKLF cells was attenuated by co-transfection with wild-
type L-catenin DNA, suggesting that this inhibitory e¡ect
was probably mediated through L-catenin.
3.5. Suppression of L-catenin^Tcf pathway by GKLF
The e¡ect of GKLF on L-catenin^Tcf function was further
evaluated by examining its inhibition on CRT in SW 480 cells.
As shown in Fig. 6, wild-type APC signi¢cantly inhibited
CRT reporter activity in a dose-dependent manner but a trun-
cated mutant (APC 331) failed to do so. These data were
consistent with previous reports from Morin et al. showing
the suppressive e¡ect of APC on the L-catenin^Tcf pathway
[2]. Similarly, co-transfection of GKLF with pTOPFLASH
reporter signi¢cantly inhibited CRT activity and the inhibition
was also dose-dependent (Fig. 6). Moreover, GKLF-mediated
inhibition of CRT was not seen in cells transfected with the
truncated non-functional GKLF construct (GKLF-1580) or
with pFOPFLASH reporter plasmid demonstrating the spec-
i¢city of the repressive e¡ects of GKLF on L-catenin^Tcf
signaling (Fig. 6).
4. Discussion
GKLF is a member of the Kru«ppel family of transcription
factors characterized by the presence of highly conserved mul-
tiple zinc-¢nger motifs at the carboxy-terminus, which repre-
sent the DNA-binding domain [15,16]. The amino-terminus
contains numerous proline and serine residues, which are
transcriptional activation domains [4]. GKLF exhibits a
highly restricted pattern of expression in tissues, and in situ
hybridization and Northern blot analyses have shown that
GKLF is expressed extensively in the gastrointestinal tract
but its level is most abundant in the colonic epithelium [17].
As stated above, our laboratory has recently shown that
Fig. 5. A: Representative graphs of £ow cytometric analysis of
HT29-pcDNA3 transfected with control (a) or L-catenin plasmid
(b), and HT29-GKLF cells transfected with control (c) or L-catenin
(d) cDNA. B: Percent of cells in the S-phase of HT29-pcDNA3 and
HT29-GKLF cells transfected with pcDNA3 or wild-type L-catenin.
Each data point represents the meanUS.E.M. of four separate ex-
periments. *P6 0.05 compared to HT29-pcDNA3 transfected with
control plasmid.
Fig. 4. Expression of (A) L-catenin or actin protein, and (B) L-cate-
nin or G3PDH mRNA in wild-type (WT) HT-29, HT29-GKLF, or
HT29-RR/RS cells. Total protein lysates (80 Wg) were assayed by
Western blot with anti-L-catenin or actin antibody, and 20 Wg of to-
tal RNA extracted from cells was subjected to Northern blot analy-
sis using human L-catenin or G3PDH cDNA probe as described in
Section 2.
Fig. 6. E¡ects of APC or GKLF on transactivation of L-catenin^
Tcf reporter (CRT). SW 480 cells were transfected with 0.5 Wg
pTOPFLASH (open bar) or pFOPFLASH (black bar) reporter plas-
mid and a di¡erent concentration (Wg) of wild-type APC, truncated
APC (APC 331), GKLF, truncated GKLF (1580) or control
pCDNA3 DNA, as indicated. CRT reporter activities are expressed
relative to the assay containing no APC or GKLF and are ex-
pressed as the meansUS.E.M. of four separate experiments.
*P6 0.05, **P6 0.01 compared to control APC (0).
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GKLF mRNA levels were signi¢cantly decreased in the dys-
plastic epithelium of the colon, and overexpression of GKLF
in HT-29 cells resulted in cell cycle arrest at the G1/S-phase
[6]. These data suggest that GKLF may function as a tumor
suppressor gene that regulates normal cell growth in the co-
lon.
The ¢ndings from the current study support the hypothesis
that GKLF exhibits its growth-suppressive e¡ect through the
APC/L-catenin pathway. In colon cancer cells, the levels of
GKLF mRNA transcript were signi¢cantly increased when
wild-type APC protein was induced. Furthermore, co-trans-
fection with wild-type APC DNA signi¢cantly stimulated
GKLF promoter activity, indicating that APC protein played
an important role in the transactivation of the GKLF gene.
These results also suggest that the expression of GKLF in
colonic mucosa may be tightly regulated by APC. These ¢nd-
ings were supported by reports from Ton-That et al. [8]. In
their study, the expression of GKLF in Min mice, a model
that bears a mutation in the murine homologue of the APC
gene, was examined. In Min mice, GKLF expression in the
intestinal epithelium was down-regulated and GKLF mRNA
levels were signi¢cantly decreased at the time of tumor devel-
opment [8]. Together, these ¢ndings suggest that an intact
wild-type APC gene is necessary for the expression of
GKLF gene. When the APC gene was mutated, as commonly
seen during the early stage of colonic tumorigenesis, GKLF
expression was suppressed, resulting in hyperproliferation of
colonic epithelium. Because APC protein is not a transcrip-
tion factor, it is likely that APC modulates GKLF promoter
activity through the interaction with other protein(s) and this
hypothesis warrants further investigation. In this report, we
have shown that the APC 331 mutant, one of the most com-
mon mutations observed in human colorectal carcinoma [18],
failed to transactivate the GKLF promoter. Because of the
complexity of APC function and its interaction with other
proteins, the regulation of GKLF gene expression by APC
needs to be further explored.
The involvement of APC/L-catenin^Tcf complex in the reg-
ulation of cell growth has recently been extensively investi-
gated. The product of the APC gene is a large protein con-
taining multiple domains that interact with many intracellular
proteins including L-catenin, Q-catenin, axin, and glycogen
synthase kinase (GSK)-3L [19]. Binding of GSK-3L, APC,
axin and L-catenin leads to phosphorylation and subsequent
degradation of L-catenin [20]. When APC protein is mutated,
the formation of a GSK-3L, APC, axin and L-catenin complex
is disrupted and results in increased cytoplasmic L-catenin
levels. Free L-catenin is then translocated to the nucleus and
interacts with Tcf-4. This interaction induces transcriptional
activation of many oncogenes including c-Myc and cyclin D1
[3,4]. In the current report, we showed that L-catenin protein
and mRNA concentrations were signi¢cantly decreased in
cells expressing GKLF and increased in cells possessing dom-
inant-negative GKLF mutant DNA indicating that GKLF
might exhibit its growth-inhibitory e¡ect through L-catenin.
These conclusions were further supported by our data show-
ing that L-catenin transfection abolished the growth-inhibi-
tory e¡ect of GKLF in HT-29 cells. Interestingly, transfection
with L-catenin has no e¡ect on DNA synthesis in HT29-
pcDNA3 cells. The lack of L-catenin e¡ect is likely due to a
high level of intrinsic L-catenin expression inherited in these
cells (data from ATCC, Rockville, MD, USA). Furthermore,
GKLF inhibited transcriptional activity of the pTOPFLASH
reporter in a dose-dependent manner, a similar property ob-
served with APC protein. Previously, our laboratory has
shown that GKLF inhibited cyclin D1 gene expression, and
cyclin D1 has been demonstrated to be one of the downstream
targets of L-catenin signaling. These data indicate that GKLF
may exert its function through the expression of L-catenin in
controlling proliferation and malignant transformation of co-
lonic epithelium. Additional studies will be necessary to de-
termine whether GKLF a¡ects the degradation and/or nuclear
translocation of L-catenin protein.
In summary, results from this study suggest that the
growth-inhibitory property of GKLF appears to be mediated,
at least in part, through the APC/L-catenin pathway. Based
upon the data presented here, we speculate that APC may
regulate GKLF expression, which, in turn, modi¢es L-catenin
levels and transcriptional activation of the downstream target
genes, including cyclin D1. When the APC gene is mutated,
the GKLF mRNA level is decreased, resulting in accumula-
tion of L-catenin and hyperproliferation of colonic epithelium.
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